Point72 Asset Management
GNCA

Point72 Asset Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Point72 Asset Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,576,385
Closed -$3.22M – 1741
2022
Q1 		$3.22M Sell
2,576,385
-76,589
-3% -$83.4K 0.01% 787
2021
Q4 		$3.08M Hold
2,652,974
– – 0.01% 760
2021
Q3 		$5.09M Buy
2,652,974
+152,974
+6% +$301K 0.02% 659
2021
Q2 		$5.85M Buy
+2,500,000
New +$6.03M 0.03% 582

Other funds holding GNCA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Point72 Asset Management's GNCA Position: Q2 2022 in Review

Point72 Asset Management sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 2,576,385 shares — an estimated $3.22M sold.

Point72 Asset Management first reported a position in GNCA in Q2 2021 and held it in 4 quarters. The position peaked at $5.85M in Q2 2021. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

  • Point72 Asset Management reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
  • Point72 Asset Management sold 2,576,385 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $3.22M.
  • Point72 Asset Management first reported a position in Genocea Biosciences, Inc. in Q2 2021 and held it in 4 quarters.
  • Point72 Asset Management's Genocea Biosciences, Inc. position peaked at $5.85M in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Point72 Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.